| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55154-4080-8 | 55154-4080 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201223 | N/A | ANDA | ANDA212297 | Cardinal Health 107, LLC | TACROLIMUS | 1 mg/1 | 2000 CAPSULE in 1 BOTTLE (55154-4080-8) |
| 70377-016-11 | 70377-016 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201223 | N/A | ANDA | ANDA212297 | Biocon Pharma Inc. | TACROLIMUS | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (70377-016-11) |
| 70377-015-11 | 70377-015 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201223 | N/A | ANDA | ANDA212297 | Biocon Pharma Inc. | TACROLIMUS | 1 mg/1 | 100 CAPSULE in 1 BOTTLE (70377-015-11) |
| 70377-014-11 | 70377-014 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201223 | N/A | ANDA | ANDA212297 | Biocon Pharma Inc. | TACROLIMUS | .5 mg/1 | 100 CAPSULE in 1 BOTTLE (70377-014-11) |